Technical Analysis for ENZ - Enzo Biochem, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Historical ENZ trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
Fell Below 20 DMA | Bearish | -3.47% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -3.47% | |
Narrow Range Bar | Range Contraction | -3.47% | |
Wide Bands | Range Expansion | -3.47% | |
20 DMA Support | Bullish | -4.02% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -4.02% | |
Narrow Range Bar | Range Contraction | -4.02% | |
Wide Bands | Range Expansion | -4.02% | |
Narrow Range Bar | Range Contraction | -3.75% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Down 5% | about 13 hours ago |
60 Minute Opening Range Breakdown | about 15 hours ago |
Down 3% | about 17 hours ago |
Down 2 % | about 17 hours ago |
Down 1% | about 17 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 03/15/2021
Enzo Biochem, Inc. Description
Enzo Biochem, Inc., an integrated life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment offers routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory, a network of approximately 30 patient service centers, a laboratory, and a full-service phlebotomy and in-house logistics department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It provides proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which offer tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts primarily in the field of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment researches and develops therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company sells its products through its direct sales force; and a network of distributors worldwide. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Acid Diabetes Antibodies Gastrointestinal Autoimmune Disease Molecular Biology Injury Clinical Research Drug Development Ophthalmic Cardiovascular Disease Lab Testing Neurological Disorders Gene Expression Obesity Peptides Genetic Engineering Metabolic Disease Metabolic Diseases Urological Disorders Dyes Search Products Biochemistry Medical Laboratory Research Products Endocrine Disorders Medical Diagnosis Diagnostic And Research Products
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.85 |
52 Week Low | 1.8 |
Average Volume | 1,347,204 |
200-Day Moving Average | 2.57 |
50-Day Moving Average | 3.25 |
20-Day Moving Average | 3.53 |
10-Day Moving Average | 3.44 |
Average True Range | 0.22 |
ADX | 24.24 |
+DI | 26.25 |
-DI | 23.42 |
Chandelier Exit (Long, 3 ATRs ) | 4.20 |
Chandelier Exit (Short, 3 ATRs ) | 3.45 |
Upper Bollinger Band | 4.02 |
Lower Bollinger Band | 3.03 |
Percent B (%b) | 0.31 |
BandWidth | 28.07 |
MACD Line | 0.07 |
MACD Signal Line | 0.10 |
MACD Histogram | -0.026 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.58 | ||||
Resistance 3 (R3) | 3.58 | 3.51 | 3.54 | ||
Resistance 2 (R2) | 3.51 | 3.45 | 3.51 | 3.53 | |
Resistance 1 (R1) | 3.42 | 3.41 | 3.39 | 3.42 | 3.51 |
Pivot Point | 3.35 | 3.35 | 3.33 | 3.35 | 3.35 |
Support 1 (S1) | 3.26 | 3.29 | 3.23 | 3.26 | 3.17 |
Support 2 (S2) | 3.19 | 3.25 | 3.19 | 3.15 | |
Support 3 (S3) | 3.10 | 3.19 | 3.14 | ||
Support 4 (S4) | 3.10 |